TORREY COPE advises and represents life science companies in a full range of regulatory, enforcement, litigation, and transactional matters involving FDA issues.
Torrey is an experienced, practical, and business-focused regulatory lawyer with scientific training and a passion for helping pharmaceutical, biotechnology, and medical technology companies solve their most challenging and cutting-edge regulatory problems, whether they involve clinical trials, marketing authorization, promotion, product safety, or other issues. Many of his clients are working at the forefront of life sciences innovation in fields such as immunotherapy, regenerative medicine, genetic testing/next generation sequencing (NGS), digital health, and artificial intelligence/machine learning (AI/ML).
Torrey also collaborates regularly with Sidley colleagues in a variety of other practice areas to help clients with matters raising complex, multidisciplinary issues. This includes colleagues in Sidley’s Healthcare and Government Strategies practices. He is also a co-leader of Sidley’s Life Sciences Transactions initiative and regularly works hand-in-hand with colleagues in the firm’s Emerging Companies and Venture Capital, Private Equity, Capital Markets, M&A, and Technology and Life Sciences Transactions groups to provide clients with integrated, strategically-oriented regulatory advice on a wide variety of transactions.
Torrey has been recognized as a “Life Sciences Star” in the FDA: Pharmaceutical category by LMG Life Sciences since 2016, and has been included in The Best Lawyers in America for FDA Law since 2018. He was also named a “Rising Star” for Life Sciences in the 2017 and 2018 LMG Expert Guides.
Before law school, Torrey conducted research in molecular biology and worked as a quality control microbiologist for a major sterile drug manufacturer.